ProfileJobs

Celgene

Suggest Edit
Healthcarebiotechdrug developmenthealthtechlife sciencesoncologypharmatherapy
Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology, and neuroinflammation.
Revenue(FY, 2018)
$15.3 B

Employee Rating

4More
TypeSubsidiary
Parent CompanyBristol-Myers Squibb
HQSummit, US
Founded1986
Websitecelgene.com
Cybersecurity ratingBMore
Celgene was founded in 1986 and is headquartered in Summit, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Celgene

Mark J. Alles

Mark J. Alles

Chairman and Chief Executive Officer
Peter N. Kellogg

Peter N. Kellogg

Executive Vice President and Chief Financial Officer
Nadim Ahmed

Nadim Ahmed

President, Hematology & Oncology
Terrie Curran

Terrie Curran

President, Inflammation and Immunology
Rupert Vessey

Rupert Vessey

Executive Vice President and President, Research and Early Development
Jonathan Biller

Jonathan Biller

Executive Vice President and General Counsel
Show more

Celgene Office Locations

Celgene has offices in Summit, Singapore and Boudry
Summit, US (HQ)
86 Morris Ave
Singapore, SG
200 Newton Road #04-01, Newton 200
Boudry, CH
Route de Perreux 1
Show all (3)

Celgene Financials and Metrics

Summary Metrics

Founding Date

1986
Celgene is a subsidiary of Bristol-Myers Squibb

Celgene Revenue

Embed Graph
View revenue for all periods
Celgene's revenue was reported to be $15.28 b in FY, 2018
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

3.6b4.8b5.5b6.5b7.7b9.3b11.2b13.0b15.3b

Revenue growth, %

18%21%21%

Cost of goods sold

306.5m425.9m299.1m340.4m385.9m420.1m438.0m461.0m587.0m

Gross profit

3.3b4.4b5.2b6.2b7.3b8.8b10.8b12.5b14.7b
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

791.3m852.7m910.1m1.1b1.2b1.2b1.3b1.4b1.4b1.5b1.6b1.7b1.7b1.9b2.0b2.1b2.3b2.3b2.5b2.8b3.0b3.0b3.3b3.3b3.5b3.8b3.9b4.0b4.4b4.5b

Cost of goods sold

61.9m68.0m63.5m127.3m126.4m94.6m72.5m71.9m74.6m80.5m80.9m86.2m86.1m98.9m97.7m104.0m100.8m109.9m105.9m110.9m107.7m113.0m111.0m118.0m135.0m126.0m157.0m140.0m151.0m167.0m

Gross profit

729.3m784.7m846.6m998.0m1.1b1.2b1.2b1.3b1.3b1.4b1.5b1.6b1.6b1.8b1.9b2.0b2.2b2.2b2.4b2.6b2.9b2.8b3.2b3.2b3.4b3.7b3.7b3.9b4.2b4.4b

Gross profit Margin, %

92%92%93%89%89%92%94%95%95%95%95%95%95%95%95%95%96%95%96%96%96%96%97%96%96%97%96%97%97%96%
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

1.4b1.9b2.1b3.2b4.1b4.9b6.2b7.0b4.2b

Accounts Receivable

706.4m945.5m960.5m1.9b2.1b

Prepaid Expenses

275.0m395.1m320.2m388.0m501.0m

Inventories

260.1m189.6m259.5m340.4m393.1m443.4m497.9m541.0m458.0m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

1.1b855.6m2.8b1.5b1.6b1.8b1.9b1.9b2.7b1.5b1.7b2.4b2.4b3.2b3.7b4.4b4.5b6.0b4.4b5.1b5.5b5.3b6.7b5.5b2.8b1.5b2.5b5.4b7.2b9.6b

Accounts Receivable

481.1m477.4m593.1m804.0m863.0m888.2m1.0b884.9m957.5m1.0b1.0b1.1b1.1b1.1b1.2b1.3b1.3b1.4b1.5b1.6b1.6b1.7b1.8b2.0b2.1b2.1b2.3b2.5b2.4b

Prepaid Expenses

312.1m303.4m240.7m246.0m271.5m242.9m322.7m275.1m224.5m385.0m442.3m387.8m386.1m382.6m509.4m774.6m692.4m703.9m787.8m760.0m612.8m633.0m734.0m671.0m605.0m824.0m819.0m521.0m445.0m732.0m

Inventories

102.5m100.8m108.7m223.2m196.4m187.5m215.6m223.2m235.9m275.4m294.4m313.3m347.8m360.0m372.0m386.7m414.3m420.9m470.6m490.4m507.9m509.0m533.0m537.0m536.0m555.0m510.0m442.0m464.0m451.0m
show all
Annual
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

880.5m1.3b1.5b1.4b2.0b1.6b2.0b2.9b4.0b

Depreciation and Amortization

54.2m71.2m84.9m471.0m635.0m

Inventories

18.7m71.0m(69.7m)(89.7m)(56.5m)(50.6m)(55.3m)(42.0m)82.0m

Accounts Payable

51.6m223.8m68.2m273.0m290.0m
Quarterly
USDQ1, 2010Q2, 2010Q3, 2010Q1, 2011Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

234.4m389.8m670.9m255.6m535.0m907.3m401.5m768.9m1.2b384.9m863.0m1.2b279.7m877.5m1.4b718.9m1.1b1.0b800.7m1.4b1.6b941.0m2.0b3.0b846.0m1.9b3.0b1.5b3.1b4.8b

Depreciation and Amortization

53.8m25.5m38.9m17.3m35.0m53.1m18.6m38.5m59.9m23.2m47.4m71.8m25.5m52.1m78.1m28.1m57.8m86.6m29.2m58.5m89.6m32.0m66.0m355.0m126.0m296.0m465.0m157.0m94.0m142.0m

Inventories

233.0k927.0k(6.4m)40.8m65.4m73.8m(25.5m)(34.0m)(46.3m)(25.8m)(45.2m)(62.6m)(7.0m)(19.1m)(33.6m)7.3m(19.2m)(27.1m)(25.6m)(45.2m)(62.3m)(10.0m)(32.0m)(37.0m)6.0m(14.0m)31.0m16.0m(5.0m)7.0m

Accounts Payable

89.6m(97.4m)(35.6m)90.3m(74.5m)(71.0m)88.4m(82.3m)97.5m150.7m111.5m(20.1m)74.3m59.2m76.8m256.2m55.0m163.9m(365.0m)219.0m28.0m(219.0m)(144.0m)(66.0m)(28.0m)71.0m84.0m
show all
USDQ1, 2010

Financial Leverage

1.3 x
Show all financial metrics

Celgene Operating Metrics

FY, 2016

Active Clinical Studies

52
Show all operating metrics

Celgene Acquisitions / Subsidiaries

Company NameDateDeal Size
Juno TherapeuticsJanuary 22, 2018$9 b
Impact BiomedicinesJanuary 07, 2018

Celgene Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

Learn more about about our premium products
SecurityScorecard logo

Celgene Online and Social Media Presence

Celgene's Trends

Embed Graph

 Celgene Frequently Asked Questions

  • When was Celgene founded?

    Celgene was founded in 1986.

  • Who are Celgene key executives?

    Celgene's key executives are Mark J. Alles, Peter N. Kellogg and Nadim Ahmed.

  • How many employees does Celgene have?

    Celgene has 8,852 employees.

  • What is Celgene revenue?

    Latest Celgene annual revenue is $15.3 b.

  • What is Celgene revenue per employee?

    Latest Celgene revenue per employee is $1.7 m.

  • Who are Celgene competitors?

    Competitors of Celgene include Amgen, Gilead Sciences and Idorsia.

  • Where is Celgene headquarters?

    Celgene headquarters is located at 86 Morris Ave, Summit.

  • Where are Celgene offices?

    Celgene has offices in Summit, Singapore and Boudry.

  • How many offices does Celgene have?

    Celgene has 3 offices.